According to the Market Statsville Group (MSG), the Global GERD and NERD Treatment Market size was valued at USD 2,628.7 million in 2023 and is expected to grow from USD 2,822.5 million in 2024 to USD 5,293.1 million by 2033, by exhibiting a CAGR of 7.9% during the forecast period (2024-2033).
The therapeutic market of GERD and NERD has a wide variety of pharmaceutical and non-pharmaceutical treatment modalities, which are directed at symptom management and the prevention of adverse events related to acid-back diffusion. Pharmacotherapy generally includes the use of proton pump inhibitors and H2-receptor antagonists, which understandably inhibit acid production by the stomach. Non-pharmacotherapy includes lifestyle treatments: diet, body mass index, and to a certain degree, elevating the head during sleep. Market growth will be on the upsurge as the incidence of GERD and NERD, globally prompted by various lifestyle modifications, dietary habits, and obesity, is increasing.
The market growth for the industry also depends on technological advancement in diagnostics techniques and various advanced treatment options along with increasing awareness and healthcare expenditure. The market environment consists of major players that are creating new therapies and devices to meet the various patient needs and demands by significantly concentrating on the effectiveness and safety profiles of existing treatments.
Gastroesophageal reflux disease (GERD) and non-erosive reflux disease (NERD) are syndromes caused by chronic acid exposure from the stomach to the esophagus. The common feature is that GERD has the characteristic of erosive damage in the esophageal mucosa appearing in endoscopy, whereas NERD has similar symptoms but does not show visible symptoms of mucosal erosions. Symptoms occurring in both include heartburn and regurgitation, and they might bring about complications such as esophagitis and Barrett.
GERD and NERD have become more common entities nowadays with mutually different causes. Important factors include lifestyle modifications that cause irregular eating schedules and increased ingestion of acidic and fatty meals. Obesity has manifested as a major risk factor because increased body weight leads to increased intra-abdominal pressure, which is also a promoting factor for acid reflux into the esophagus. Furthermore, modern sedentary lifestyles coupled with stress increase the occurrence of GERD and NERD which causes further reduced esophageal sphincter function, which aggravates the symptoms of reflux.
Therefore, with the increase in the aging population, the occurrence of GERD and NERD elevates the demand for remedies. These trends describe the elaborate interplay that dietary patterns, lifestyle choices, and demographic shifts have developed to shape the epidemiology of GERD and NERD worldwide, making rigorous preventive and therapeutic enterprises sensible in controlling these chronic conditions.
Chronic administration of proton pump inhibitors in GERD and NERD is significantly challenging, as notwithstanding their proven efficacy in decreasing acid production in the stomach, a myriad of complications ensue from their long-term use, including increased risk for bone fractures, especially in elderly patients, secondary to decreased calcium absorption. Other reported complications include vitamin and mineral deficiencies, such as magnesium, combined with vitamin B12 and iron deficiencies leading to anemia and neurological issues.
There is also the concern that a PPI increases susceptibility to gastrointestinal infections, such as Clostridium difficile, and the rebound acid hypersecretion that occurs when the medication is stopped as a state that can pose a risk for further exacerbating symptoms. Management of such risks warrants careful monitoring, with particular consideration of alternative options of treatment, underscoring the need for balancing therapeutic benefit against potential long-term adverse consequences in clinical practice.
The study categorizes the GERD and NERD Treatment market based on drug class, dosage form, and end-users area at the regional and global levels.
Based on the drug class, the market is divided into the Antacids, H2 Receptor Blocker, and Proton Pump Inhibitors segment. The proton pump inhibitors accounted for the largest market share in the global GERD and NERD Treatment market. PPIs are prescribed quite commonly for their potent effects at suppressing acid to manage symptoms and promote the healing of esophageal erosions associated with both GERD and NERD. Their very effective mode of action is the final inhibition of acid production in the stomach, superior to H2 receptor blockers and antacids for controlling gastric acid secretion over the long term. Besides, PPIs are usually well-tolerated and have a favorable safety profile if applied properly; these are some reasons the wide acceptance and dominance of their use have propagated in treating these gastrointestinal disorders.
Based on the regions, the global market of GERD and NERD Treatment has been segmented across North America, Europe, the Middle East & Africa, South America, and Asia-Pacific. North America holds a leading position in the market for the treatment of GERD and NERD because of several advantageous factors. This is because the disease is highly prevalent based on dietary patterns, obesity rates, and lifestyle factors dominant in the general population of this region. Advanced healthcare infrastructure and significant investments in research and development further augment diagnostic capabilities and treatment options, driving market growth.
North America houses companies that top in the number of present novel therapies developed due to company-friendly regulations and high market demand for such matters. Besides, high expenditure on therapies and considerable insurance coverage for the same support the access by patients to new treatments and therapies. All these make up a very enabling environment to foster dominance in the market, thereby placing North America at the leading edge in tackling the rising healthcare needs associated with GERD and NERD management.
The global GERD and NERD therapeutic market is highly competitive, with major pharmaceutical companies easily inventing agents for a standard cure. The key players in this sector therefore are involved in the development of new treatments and increasing the efficiency of treatment, which remains challenged by several side effects and low rate of adherence to the medication. This further lays the groundwork for technological developments and strategic cooperation.
Major players in the global GERD and NERD Treatment market are:
Frequently Asked Questions
Want to Review Complete Market Research Report
Budget constraints? Get in touch with us for special pricing
Request for Special PricingCustomize this Report
Related Reports
Medical Cannabis Oil Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024Novel Vaccine Delivery System Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Lysosomal Storage Disease Treatment Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024Single-Use Bioprocessing Market 2022: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Mar 2024Liver Health Supplements Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024